Cargando…
No association between TP53 Arg72Pro polymorphism and ovarian cancer risk: evidence from 10113 subjects
The TP53 gene product is an important regulator of cell growth and a tumor suppressor. The association between TP53 Arg72Pro polymorphism and ovarian cancer risk has been widely investigated, but the results are contradictory. We therefore searched the PubMed, EMBASE and Chinese Biomedical databases...
Autores principales: | Zhang, Anqi, Shi, Ting-Yan, Zhao, Yuan, Xiang, Junmiao, Yu, Danyang, Liang, Zongwen, Xu, Chaoyi, Zhang, Qiong, Hu, Yue, Wang, Danhan, He, Jing, Duan, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762548/ https://www.ncbi.nlm.nih.gov/pubmed/29348863 http://dx.doi.org/10.18632/oncotarget.22603 |
Ejemplares similares
-
The Neuronal Ischemic Tolerance Is Conditioned by the Tp53 Arg72Pro Polymorphism
por: Ramos-Araque, Maria E., et al.
Publicado: (2018) -
The human Tp53 Arg72Pro polymorphism explains different functional prognosis in stroke
por: Gomez-Sanchez, Jose C., et al.
Publicado: (2011) -
The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility
por: Zhao, Zhiguang, et al.
Publicado: (2018) -
Arg72Pro Polymorphism of TP53 Gene and the Risk of Skin Cancer: a Meta-Analysis
por: Ye, Jun, et al.
Publicado: (2013) -
Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer
por: YONEDA, TOMOKO, et al.
Publicado: (2013)